Kanya Rajangam - Pres. & Chief Med. & Dev. Off. at Senti Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. & Chief Med. & Dev. Off.
Issuer Symbol
SNTI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kanya Rajangam since 14 Mar 2025

Holdings reported by Kanya Rajangam for Senti Biosciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 74,843 $60,622 $0.8100 09 Mar 2026 Direct
Series A Convertible Preferred Stock 0 $0 $2250.00 10 Mar 2025 Iyer Family Revocable Trust dated Aug 26 2012 Common Stock

Transactions reported by Kanya Rajangam for Senti Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.